Discover how Cell and Gene Therapy AI (CGTAI), CRISPR gene editing and advanced cell therapies could transform treatments for ...

Application of the high-precision technique is part of a clinical trial to treat a genetic disease that can cause liver and ...

Gene therapy is no longer the future of medicine—it's reality. Treatments that replace, silence or edit genes are already ...

AI maps gene switches to steer dodo revival via pigeon DNA editing Ai-pinpointed DNA switches chart a path to sculpt ...

Colossal Biosciences on October 14, 2026 unveiled GenoMorph, an artificial-intelligence platform developed to identify ...

Some people are born with a defect in their genetic material that prevents their immune system from functioning properly. In ...

Vitamin B3 may help scientists turn the body’s natural cancer-fighting cells into a more powerful treatment. In an early ...

Software, genome sequencing, drug discovery and cloud platforms lead adoption, while precision medicine, diagnostics and AI-enabled services create new opportunities.Dublin, Oct. 19, 2026 (GLOBE ...

Cellectis (NASDAQ:CLLS) outlined plans to advance two preclinical in vivo gene-editing candidates for severe forms of dyslipidemia, targeting hypertriglyceridemia and hypercholesterolemia through ...

Pharmaceutical & Biotech Stock Introductory Series, Part 2, Episode 12 (Final Episode) / 12 Episodes ...

OpenAI has acquired biotech AI startup Orchestra Bio for its Rosalind biology suite. Anthropic, which bought Coefficient Bio ...